ExpreS2ion Biotech: New patent application in Hong Kong - Redeye

Redeye briefly comments on ExpreS2ion’s announcement of a published Hong Kong patent application covering glyco-engineering methods within the ExpreS2 platform. While early-stage and not value-defining in isolation, the filing strengthens the company’s platform IP with potentially broad application across multiple vaccine and immunotherapy programs and supports long-term partnering opportunities, particularly in Asia.

Länk till analysen i sin helhet: https://www.redeye.se/research/1159383/expres2ion-biotech-new-patent-application-in-hong-kong?utm_source=finwire&utm_medium=RSS